Financial Services AstraZeneca to Acquire Alexion, Accelerating the Company’s Strategic and Financial Development AIT News Desk Dec 13, 2020 Greater scientific presence in immunology by adding Alexion's innovative complement-technology platforms and strong pipeline AstraZeneca and Alexion…
Life Sciences Sage Therapeutics Appoints Barry Greene to Board of Directors AIT News Desk Oct 2, 2020 Sage Therapeutics, Inc., a biopharmaceutical company committed to developing novel therapies with the potential to transform the lives of people with…
Life Sciences RenalytixAI to Collaborate with AstraZeneca to Improve Outcomes for Patients with Chronic Disease AIT News Desk Aug 21, 2020 Parties to adopt multi-phase approach to develop precision medicine strategies to optimize treatment of cardiovascular, renal and metabolic disease…
Life Sciences ArcherDX Announces Strategic Collaboration With AstraZeneca to Develop Personalized Cancer… AIT News Desk May 26, 2020 ArcherDX, Inc., announced a strategic collaboration with AstraZeneca to develop assays to support multiple planned Phase 3 clinical trials for…
IoT BrightInsight Announces Global Digital Health Partnership With AstraZeneca AIT News Desk Mar 25, 2020 AstraZeneca Selects the Brightinsight Platform to Build and Manage Its Digital Health Solutions Within a Regulatory-Compliant Environment…
Hot Startups AstraZeneca’s ‘Ambition Zero Carbon’ Strategy to Eliminate Emissions by 2025 and Be Carbon Negative… AIT News Desk Jan 24, 2020 The $1 Bn Programme Will Include the Launch of Next-Generation Respiratory Inhalers and a Wide Range of Energy Initiatives to Reduce Climate Impact to…
AIT Featured Posts Net-Zero or Negative Carbon: Why Should Everyone Know What’s Happening at WEF 2020? Sudipto Ghosh Jan 23, 2020 Read the latest Zero-Carbon updates from WEF 2020 In the last 18 months, you must have come across terms such as "Mission Zero Carbon" and Negative…
AIT Featured Posts $90 Million Injected into Drug Discovery Company BenevolentAI; Focus Shifts to Making Medicines… Sudipto Ghosh Sep 23, 2019 BenevolentAI applies its technology designed to enable better data-driven decisions to find ways to treat disease and personalize drugs for specific…
News BERG Forms Research Collaboration with AstraZeneca to Identify New Therapeutic Targets to Treat… PRNewswire Aug 28, 2017 Collaboration to Focus on a Disease Target in Parkinson's Disease With Berg's Interrogative Biology Technology BERG, a biopharmaceutical…